Day 1 :
Keynote Forum
Shyam B Mehta
Teva Pharmaceuticals, USA
Keynote: A case study on manufacturing issues during processing of a lyophilized drug product
Time : 10:10-10:50
Biography:
Abstract:
Keynote Forum
Mallikarjun Narayan Dixit
Accutest Biologics Private Limited, India
Keynote: Challenges in development of biologics and biosimilars: An overview stability and validation
Time : 10:50-11:30
Biography:
Abstract:
- Biopharmaceutics | Drug Discovery & Development | Biologic Drugs | Biological Medicine | Array of Clinical Trials in Biopharmaceutics
Location: Hilton Philadelphia Airport
Session Introduction
Mallikarjun Narayan Dixit
Accutest Biologics Private Limited, India
Title: Immunogenicity of protein biotherapeutics: Case studies on ADA methods
Time : 11:50-12:20
Biography:
Abstract:
Nayanabhirama Udupa
Manipal University, India
Title: Effective oral drug delivery for the treatment of diabetes mellitus
Time : 12:20-12:50
Biography:
Abstract:
Santosh K Singh
Banaras Hindu University, India
Title: Evaluation of anticancer and apoptosis inducing activity of Amoora rohituka W.A. in human breast cancer cell line, MCF-7
Time : 13:50-14:20
Biography:
Abstract:
Yesenia Elizabeth Cevallos Villacrés
University of Calabria, Italy
Title: A protocol stack paradigm of gene expression
Time : 14:20-14:50
Biography:
Abstract:
Shyam B Mehta
Teva Pharmaceuticals, USA
Title: Product on stopper’ in a lyophilized biologic drug product: Cosmetic defect or a product quality concern?
Time : 14:50-15:20
Biography:
Abstract:
Hong Ngoc Thuy Pham
Nha Trang University, Australia
Title: Maximizing saponin yield and antioxidant capacity of Catharanthus roseus (L.) G. Don (Patricia White cultivar) stem by ultrasound-assisted extraction
Time : 15:20-15:50
Biography:
Abstract:
Rubi Mahato
Fairleigh Dickinson University, USA
Title: Nanoemulsion as targeted drug delivery system for cancer therapeutics
Time : 16:10-16:40
Biography:
Abstract:
Nanoemulsion serves as an attractive vehicle for the delivery of drugs, nucleic acids as well as imaging agents. Recently nanoemulsions have been extensively used for cancer diagnostics, imaging and therapy, especially due to their favorable properties to efficiently solubilize poorly aqueous soluble drugs, biocompatibility, high stability in vitro and in vivo, and their ability to accumulate in pathological areas with defective vasculatures. Since nanoemulsions are submicron emulsions with the droplet size falling in colloidal dispersion range, they impart the benefit of overcoming the anatomical and physiological barriers associated with drug delivery to the complex diseases such as cancer. Moreover, nanoemulsions can be engineered to carryout multiple functions by surface modification and encapsulation of pharmaceutical ingredients. Surface modification can be done by imparting the surface charge, attaching a targeting ligand, cell penetrating moieties, stimuli-sensitive groups and fluorescent dye, whereas the core can be loaded with drug, contrast agent and imaging agents. Such multifunctionality of nanoemulsion can be tailored to fit the requirement, hence smart nanoemulsions can be prepared.
Kamna Srivastava
University of Delhi, India
Title: Role of angiotensinogen gene polymorphism in blood pressure lowering response to angiotensin converting enzyme inhibitors
Time : 16:40-17:10
Biography:
Abstract:
Xiping Zhan
Howard University, USA
Title: A reexamination of the role of dopamine receptors in harmaline-induced tremor
Time : 17:10-17:40